Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-11

FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Mylan Pharmaceuticals for a generic amlodipine/valsartan combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)